01 4Fabre-Kramer Pharmaceuticals
01 4TABLET, EXTENDED RELEASE;ORAL
01 4DISCN
01 4EXXUA
01 4USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXXUA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 18.2MG BASE
Packaging :
Approval Date : 2023-09-22
Application Number : 21164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXXUA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 36.3MG BASE
Packaging :
Approval Date : 2023-09-22
Application Number : 21164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXXUA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 54.5MG BASE
Packaging :
Approval Date : 2023-09-22
Application Number : 21164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXXUA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 72.6MG BASE
Packaging :
Approval Date : 2023-09-22
Application Number : 21164
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?